Does Agilon Health (AGL) have what it takes to be a top stock pick for momentum investors? Let's find out.
If you are looking for stocks that have gained strong momentum recently but are still trading at reasonable prices, Agilon (AGL) could be a great choice. It is one of the several stocks that passed through our 'Fast-Paced Momentum at a Bargain' screen.
agilon health is rated Buy with a $177 price target, reflecting a robust Q1 beat and a positive inflection in financials. Q1 2026 delivered $1.42B revenue (+$40M vs. consensus), $54M adjusted EBITDA (+162% YoY), and raised full-year guidance across all key metrics. Margin expansion is driven by a new data pipeline, scaled clinical programs, disciplined payer contracting, and AI-driven risk scoring now fully operational.
| Health Care Providers & Services Industry | Healthcare Sector | Timothy O'Rourke CEO | CXA Exchange | US00857U2069 ISIN |
| US Country | 856 Employees | - Last Dividend | 31 Mar 2026 Last Split | - IPO Date |
agilon health, inc. specializes in delivering comprehensive healthcare services tailored specifically for seniors through a network of primary care physicians across the United States. Established initially as Agilon Health Topco, Inc., the company underwent a rebranding to its current name, agilon health, inc., in March 2021. Founded in 2016, agilon has positioned its headquarters in Austin, Texas. The organization caters to the complete healthcare needs of its patients, adopting a unique model akin to a subscription-based service charged per member per month, ensuring focused and sustained healthcare delivery.